Camu-Camu Prebiotic and Immune Checkpoint Inhibition in Patients With Non-small Cell Lung Cancer and Melanoma

Clinical trial NCT05303493 · COMPLETED

Trial details

NCT number: NCT05303493
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

NSCLC Stage IV Melanoma Stage IV Unresectable Melanoma Advanced Non-Small Cell Lung Cancer

Start date: 2022-06-29
Primary completion: 2025-07-15
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.